- Home
- VRNT vs NKTR Comparison
VRNT vs NKTR Comparison
Compare VRNT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNT
- NKTR
- Stock Information
- Founded
- VRNT 1994
- NKTR 1990
- Country
- VRNT United States
- NKTR United States
- Employees
- VRNT N/A
- NKTR N/A
- Industry
- VRNT EDP Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- VRNT Technology
- NKTR Health Care
- Exchange
- VRNT Nasdaq
- NKTR Nasdaq
- Market Cap
- VRNT 1.2B
- NKTR 1.1B
- IPO Year
- VRNT N/A
- NKTR 1994
- Fundamental
- Price
- VRNT $20.51
- NKTR $61.56
- Analyst Decision
- VRNT Hold
- NKTR Strong Buy
- Analyst Count
- VRNT 6
- NKTR 5
- Target Price
- VRNT $25.60
- NKTR $89.00
- AVG Volume (30 Days)
- VRNT 1.7M
- NKTR 689.7K
- Earning Date
- VRNT 12-03-2025
- NKTR 11-06-2025
- Dividend Yield
- VRNT N/A
- NKTR N/A
- EPS Growth
- VRNT 10.62
- NKTR N/A
- EPS
- VRNT 0.74
- NKTR N/A
- Revenue
- VRNT $893,843,000.00
- NKTR $62,600,000.00
- Revenue This Year
- VRNT $7.73
- NKTR N/A
- Revenue Next Year
- VRNT $5.67
- NKTR N/A
- P/E Ratio
- VRNT $27.83
- NKTR N/A
- Revenue Growth
- VRNT N/A
- NKTR N/A
- 52 Week Low
- VRNT $14.15
- NKTR $6.48
- 52 Week High
- VRNT $34.80
- NKTR $66.92
- Technical
- Relative Strength Index (RSI)
- VRNT 68.04
- NKTR 56.89
- Support Level
- VRNT $20.17
- NKTR $53.29
- Resistance Level
- VRNT $20.31
- NKTR $61.81
- Average True Range (ATR)
- VRNT 0.04
- NKTR 3.56
- MACD
- VRNT 0.01
- NKTR 0.18
- Stochastic Oscillator
- VRNT 100.00
- NKTR 88.53
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.